Related Experiment Video
Updated: Sep 3, 2026

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
Published on: December 17, 2021
Multipathway Aggregation Drives Concentration-Dependent Amyloid Polymorphism and Time-Dependent Morphological
Kamal Bhandari1, Wuzhou Xiong1,2, Tianyi Hou3
1Department of Physics and Astronomy, Clemson University, Clemson, South Carolina29634, United States.
Abstract:
Amyloid aggregation into polymorphic fibrils is central to many neurodegenerative and systemic diseases, yet the physical origins of fibril polymorphism and time-dependent morphological evolution remain unclear. Because mature fibril morphologies are separated by high energy barriers, direct interconversion is unlikely. Here, we propose a multipathway aggregation model in which oligomeric nuclei with distinct sizes and chemical potentials seed different fibril morphologies. The abundance and temporal evolution of these polymorphs are governed by pathway-specific fibrillization barriers and fibril stabilities, allowing kinetically favored morphologies to dominate early but to be replaced by more stable forms over time. Differences in nucleus size further introduce concentration dependence, biasing aggregation toward different intermediates and fibril morphologies at low versus high concentrations. This framework helps rationalize the substantial concentration disparity between in vitro experiments and in vivo environments and highlights the importance of considering multipathway, concentration-dependent aggregation in studying amyloidosis and designing antiamyloidosis strategies.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Cooperative Allosteric Transitions
Alzheimer Disease ll: Pathophysiology

